Literature DB >> 21553321

Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease.

Megan M Lo1, Shelia Salisbury, Philipp E Scherer, Susan L Furth, Bradley A Warady, Mark M Mitsnefes.   

Abstract

In contrast to the general population, patients with chronic kidney disease (CKD) experience increased total adiponectin levels despite an increased prevalence of cardiovascular disease. Adiponectin circulates as trimer, low molecular weight (LMW), and high molecular weight (HMW) complexes. The distribution and role of each subfraction in CKD is unknown. This cross-sectional analysis examined the association of serum adiponectin and its subfractions with known cardiovascular risk factors in 105 children (median age 12 years; 56% male) enrolled into the Chronic Kidney Disease in Children (CKiD) study, an observational cohort study of children with CKD stage 2-4.HMW accounted for 46% of total adiponectin, followed by LMW (34%) and trimer (20%). In multivariable analysis, LMW was independently associated with iohexol glomerular filtration rate (GFR) (p = 0.004) and was higher in pubertal versus prepubertal children (p = 0.005). HMW/LMW ratio was independently associated with age and iohexol GFR (all p < 0.001). Unexpectedly, systolic blood pressure was positively correlated with HMW (p = 0.01), and HMW/LMW ratio (p = 0.007) and inversely correlated with LMW (p = 0.009). Among subfractions, only LMW was significantly correlated with left ventricular mass (LVM) index (p = 0.05). In multivariable analysis, decreased LMW was independently associated with higher LVM index [β= -0.25, 95% confidence interval (CI) -0.50, -0.03, p=0.04) after adjustment for body mass index (BMI), age, and blood pressure.The higher total adiponectin levels in children with CKD are associated with higher HMW and lower LMW. This imbalance may be an important biomarker for increased cardiovascular risk despite higher levels of total adiponectin in children with CKD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553321      PMCID: PMC3366590          DOI: 10.1007/s00467-011-1906-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  43 in total

1.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

Review 2.  Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

Authors:  M Bouskila; U B Pajvani; P E Scherer
Journal:  Int J Obes (Lond)       Date:  2005-03       Impact factor: 5.095

3.  Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.

Authors:  Fitsum Guebre-Egziabher; Jacques Bernhard; Tohru Funahashi; Aoumeur Hadj-Aissa; Denis Fouque
Journal:  Nephrol Dial Transplant       Date:  2004-12-07       Impact factor: 5.992

4.  Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

Authors:  Soon Jun Hong; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh; Young Moo Ro
Journal:  Blood Press       Date:  2004       Impact factor: 2.835

5.  Adiponectin-mediated modulation of hypertrophic signals in the heart.

Authors:  Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

6.  Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.

Authors:  Peter Stenvinkel; Alicia Marchlewska; Roberto Pecoits-Filho; Olof Heimbürger; Zhengzhong Zhang; Catherine Hoff; Cliff Holmes; Jonas Axelsson; Sivonne Arvidsson; Martin Schalling; Peter Barany; Bengt Lindholm; Louise Nordfors
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

Authors:  G J Schwartz; L P Brion; A Spitzer
Journal:  Pediatr Clin North Am       Date:  1987-06       Impact factor: 3.278

9.  Plasma adiponectin concentration before and after successful kidney transplantation.

Authors:  J Chudek; M Adamczak; H Karkoszka; G Budziński; W Ignacy; T Funahashi; Y Matsuzawa; L Cierpka; F Kokot; A Wiecek
Journal:  Transplant Proc       Date:  2003-09       Impact factor: 1.066

10.  Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.

Authors:  Antje Böttner; Jürgen Kratzsch; Grit Müller; Thomas M Kapellen; Susann Blüher; Eberhard Keller; Matthias Blüher; Wieland Kiess
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  11 in total

Review 1.  Adiponectin: mechanistic insights and clinical implications.

Authors:  A T Turer; P E Scherer
Journal:  Diabetologia       Date:  2012-06-12       Impact factor: 10.122

2.  Isolation and quantitation of adiponectin higher order complexes.

Authors:  Joseph M Rutkowski; Philipp E Scherer
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression.

Authors:  Joseph M Rutkowski; Johanne Pastor; Kai Sun; Sun K Park; I Alexandru Bobulescu; Christopher T Chen; Orson W Moe; Philipp E Scherer
Journal:  Kidney Int       Date:  2016-11-30       Impact factor: 10.612

Review 4.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

5.  Adiponectin promotes functional recovery after podocyte ablation.

Authors:  Joseph M Rutkowski; Zhao V Wang; Ae Seo Deok Park; Jianning Zhang; Dihua Zhang; Ming Chang Hu; Orson W Moe; Katalin Susztak; Philipp E Scherer
Journal:  J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 10.121

6.  Association of serum adiponectin level with albuminuria in chronic kidney disease patients.

Authors:  Ha Yeon Kim; Eun Hui Bae; Seong Kwon Ma; Dong Wan Chae; Kyu Hun Choi; Yong-Soo Kim; Young-Hwan Hwang; Curie Ahn; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2015-10-07       Impact factor: 2.801

7.  Adiponectin is a Good Marker for Metabolic State among Type 1 Diabetes Mellitus Patients.

Authors:  Hamdollah Karamifar; Narges Habibian; Gholamhosein Amirhakimi; Zohre Karamizadeh; Abbas Alipour
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

8.  The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.

Authors:  Anastasia Markaki; John Kyriazis; Kostas Stylianou; George A Fragkiadakis; Kostas Perakis; Andrew N Margioris; Emmanuel S Ganotakis; Eugene Daphnis
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Differential transendothelial transport of adiponectin complexes.

Authors:  Joseph M Rutkowski; Nils Halberg; Qiong A Wang; William L Holland; Jonathan Y Xia; Philipp E Scherer
Journal:  Cardiovasc Diabetol       Date:  2014-02-20       Impact factor: 9.951

10.  High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study.

Authors:  Su Hyun Song; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Seong Kwon Ma; Kook Hwan Oh; Curie Ahn; Soo Wan Kim; Eun Hui Bae
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.